Omega Protein Corp

Omega Protein — Investor Presentation (September 2015)

25 slides from Omega Protein's investor presentation, Sep 17, 2015

  1. Slide 1: Healthy Lives Through Better Nutrition

    OMEGA ROMEO. Healthy Lives Through Better Nutrition

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements ‘The statements contained in this presentation that are not historical facts are forward-looking statements that imove a numberof risks and uncertainties. Forward-looking information may be based on projections, predictions and estimates. In this presentation and in report

  3. Slide 3: Omega Protein At A Glance

    Omega Protein At A Glance our Vision company for N to be the trusted = \ . innovative, healthy “NUTRITION solutions industry — es. manufacturing ~ animal & human facilities rain REVENUE vessels S338i TTM 6/30/15 \EXPORT to 2: + \ 40+ es ~1,100 NYSE employees WORLD-WIDE

  4. Slide 4: Leveraged to Key Health & Nutrition Trends

    Leveraged to Key Health & Nutrition Trends Sales ROWTH 201 015e| (2 bil lion HEALTH AND | WELLNESS products \_ versus conventional: | % = AD 57% | Sn ee consumers WANT GROWING ‘y more PROTEIN: Global Middle Class> 4 ww 6 ( per capita global 1.8B 3.2B 4.9B | FISH CONSUMPTIOJ \ 2009 2020 2030 _) 1960

  5. Slide 5: Recent Strategic Steps to Growth

    Recent Strategic Steps to Growth OMEGA PROTEIN HAS TAKEN SEVERAL STEPS TO CREATE GROWTH OPPORTUNITIES. Expanded into Dietary Supplements 2010 Protein Platform Beyond Menhaden e 2014 Expanded Fatty Acid Platform Beyond Menhaden Expanded Value Chain OMEGA OME.

  6. Slide 6: Attractive End Markets

    Attractive End Markets Sales by Customer Segment Estimated TTM 6/30/15 Companion Livestock ‘Aquaculture ee Supplement OMEGA OME.

  7. Slide 7: Well-Positioned with Protein & Oil Products

    Well-Positioned with Protein & Oil Products % of Revenue by Product Category TTM 6/30/15 WOPROTEIN SPECIALTY Houserany | ACIDS OTHER, NUTRIENTS Proteins MARINE, DAIRY PLANT OMEGA RMN: ’

  8. Slide 8: Global Distribution Network

    Global Distribution Network % of TTM 6/30/2015 Revenue

  9. Slide 9: Strategic & Vertical Business Model

    Strategic & Vertical Business Model = A \ 4 nS {e_2 J)

  10. Slide 10: Value Proposition

    Value Proposition LEADER IN SUSTAINABLY "acl CUSTOMER PROTEIN & SOURCED & FATTY ACID PRODUCTS TRUST INNOVATION | OMEGA RMN: ’

  11. Slide 11: Growth Objectives Focused on Value-Creation

    Growth Objectives Focused on Value-Creation CREATE SHAREHOLDER INCREASE DECREASE PROFITS & EARNINGS CASH FLOWS VOLATILITY RESULTS NEW PRODUCTS IMPROVE GROWSALES & OPERATING & & CAPTURE CAPABILITIES CAPITAL MARKET EFFICIENCY SHARE LEVERS AB OMEGA rt ‘© PROTEIN"

  12. Slide 12: Financial Highlights

    OMEGA aOMEOK FINANCIAL HIGHLIGHTS

  13. Slide 13: Financial Objectives Drive Capital Allocation

    Financial Objectives Drive Capital Allocation FINANCIAL [A [. OBJECTIVES bev | = REDUCE EARNINGS & Woman MA ENCE CASH FLOWS. INTENSITY CAPITAL ALLOCATION PRIORITIES REINVEST IN THE BUSINESS GROWTH Maintenance CapEX Technology CapEX Mergers & Acquisitions Regulatory CapEX Organic Growth OMEGA OME. 13

  14. Slide 14: Investing in Growth and Diversification

    $350 Investing in Growth and TOTAL REVENUE (MILLION US. S) ANIMAL NUTRITION HUMAN NUTRITION FISH MEAL ME FsH on $300 Fish OL I PLavro omTHeR DAIRY PROTEIN $250 Ld La NUTRACEUTICALS $200 _ —— $100 $50 $0 AQOMEGA PROTEIN" 6/30/15 TTM Diversification OBJECTIVE 1: Grow Earnings & Cash Flows © Newlines o

  15. Slide 15: Income Statement Highlights

    Income Statement Highlights REVENUE Million US. $ Strong industry fundamentals yield healthy $252 margins over time $309 1 ee $174 —a 4 ' i Seasonal factors can create short-term 1 1 volatility 1 1 2010 ©-2011-=«2012- 20182014 TTM ENS. Strong cash flow generation w Animal mw Human Million US. $ Mill

  16. Slide 16: Favorably Positioned vs. Peers

    Favorably Positioned vs. Peers ADJUSTED EBIT* MARGIN despite volatility —e OPERATING MARGINS compare FAVORABLY to peers 360 25% 23% $60 20% $40 rot PEER GROUP MEDIAN TTM EBIT % ! ' 15% ot 13.1% Food Ingredients ba 1S © 11.5% Vitamins, Minerals & Supplements | 1 \ 10% 1 so I | 7.5% Protein Processing

  17. Slide 17: Balance Sheet Highlights

    Balance Sheet Highlights DEBT* BALANCE 12/31/14 CREDIT METRICS Million US. $ Debt: EBITDA 0.5x Debt: Book Capital 12% Available Liquidity $65M 2010 2011 2012 2013 2014 *Debtincludes capital leases Strong Balance Sheet and Ample Liquidity provide Financial Flexibility to WITHSTAND VOLATILITY EXECUTE

  18. Slide 18: Appendix

    OMEGA ROMEO. APPENDIX

  19. Slide 19: Omega Protein Gross Profit Drivers

    Omega Protein Gross Profit Drivers Animal Segment Gross Profit $72.6M 29.8% of revenues Omega Protein Consolidated Gross Profit $77.6M 25.1% of revenues Human Segment Gross Profit $5.0M 7.7% of reverues 2014 Results Displayed OMEGA OMEN *

  20. Slide 20: Animal Nutrition Gross Profit Drivers

    Animal Nutrition Gross Profit Drivers REVENUE PERTON KEY DRIVERS. Market Prices Forward Contracting Product Mix $1,390 | REVENUE SALES Animal VOLUME Segment KEY DRIVERS | Gross Profit Production Catch $72.6M eee $171.2M 29.8%of revenues Inventory Carryover COST PER $976 TON KEY DRIVERS we 2014Resutt

  21. Slide 21: Human Nutrition Gross Profit Drivers

    2 Human Nutrition Gross Profit Drivers REVENUE KEY DRIVERS = Plant Oil Sales Fish Oil Sales Dairy Protein Sales Other Nutraceutical Sales Human Tolling Revenues enmeneGrees Profit $5.0M GROSS 7.7% of revenues MARGIN % KEY DRIVERS Capacity Utilization LEGEND Production Costs Market Prices ees 2014 Re

  22. Slide 22: OME Key Historical Drivers

    OME Key Historical Drivers 2009 2010 2011 2012 2013 2014 ANIMAL NUTRITION SEGMENT FINANCIAL DRIVERS: A Fish Catch (short tons) 469,067 Implied Total Yield 38.4% (C) Total Production (tons) 180,109 () Volume Sold 204,488 cc) Revenue Per Ton $845 @ Cost perTon $07) FINANCIAL RESULTS ($inmillions) (G=(

  23. Slide 23: Supply Not Keeping Up With Demand

    Supply Not Keeping Up With Demand GLOBAL FISH MEAL PRODUCTION GLOBAL FISH OIL PRODUCTION 6.226 5 s65 eso we eae 993 1061 1058 1,032 1,080 921 g94 973 5,092 5, 5052 4972 4903 ag —— — RISING DEMAND + FLAT SUPPLY = RISING PRICES OMEGA eet PROTEIN REVENUE PER $1063 54052 shoes TON* US.S Trailing 10-year

  24. Slide 24: Regulation G Reconciliation

    Regulation G Reconciliation ‘The following table provides reconciliation ofAdjusted EBIT andAdjusted EBITDA*, non-GAAP (Generally Accepted Accounting Principles) financial measures, to net income, the most directly comparable financial measure calculated and presented in accordancewith GAAP, for fis

  25. Slide 25: Regulation G Reconciliation

    Regulation G Reconciliation *Adjusted EBIT represents net income before interest expense, income tax, investigation charge, net loss on disposal of assets, the Gulf Coast Claims Facility (Deepwater Horizon claim) and 2008 and 2005 hurricane litigation settlements, impairment of intangible assets and

Omega Protein — Investor Presentation (September 2015) on 6ix